Two-year follow-up of the COVID-19 pandemic in Mexico

A Loza, RM Wong-Chew… - Frontiers in Public …, 2023 - frontiersin.org
Background After the initial outbreak in China (December 2019), the World Health
Organization declared COVID-19 a pandemic on March 11th, 2020. This paper aims to …

Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS‐CoV‐2 variants

KM Ali, PMA Rashid, AM Ali, AM Tofiq… - European Journal of …, 2023 - Wiley Online Library
Background The pandemic of coronavirus disease 2019 (COVID‐19) has a broad spectrum
of clinical manifestations. The severe acute respiratory syndrome coronavirus‐2 (SARS …

Prevalence of symptoms, comorbidities, and reinfections in individuals infected with wild-type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western …

M Peña Rodríguez, J Hernández Bello… - Frontiers in Public …, 2023 - frontiersin.org
Introduction The variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have been classified into variants of interest (VOIs) or concern (VOCs) to prioritize global …

Comparing the evolutionary dynamics of predominant SARS-CoV-2 virus lineages co-circulating in Mexico

HG Castelán-Sánchez, L Delaye, RPD Inward… - Elife, 2023 - elifesciences.org
Abstract Over 200 different SARS-CoV-2 lineages have been observed in Mexico by
November 2021. To investigate lineage replacement dynamics, we applied a phylodynamic …

Omicron-BA. 1 dispersion rates in Mexico varied according to the regional epidemic patterns and the diversity of local Delta subvariants

S Zárate, B Taboada, M Rosales-Rivera… - Viruses, 2023 - mdpi.com
Purpose: The Omicron subvariant BA. 1 of SARS-CoV-2 was first detected in November
2021 and quickly spread worldwide, displacing the Delta variant. In this work, a …

Genomic epidemiology of SARS-CoV-2 in Senegal in 2020-2021

AA Ba, R Coppée, A Dieng, J Manneh, M Fall… - The Journal of Infection …, 2024 - jidc.org
Abstract Introduction: In Senegal, molecular diagnosis was widely used for the detection and
management of COVID-19 patients. However, genomic surveillance was very limited in the …

SARS-CoV-2 Vaccine Effectiveness in Hospitalized Patients: A Multicenter Test-Negative Case–Control Study

I Thirión-Romero, R Fernández-Plata… - Vaccines, 2023 - mdpi.com
Background: Phase III clinical trials have documented the efficacy of the SARS-CoV-2
vaccines in preventing symptomatic COVID-19. Nonetheless, it is imperative to continue …

SARS-CoV-2 BW lineage, a fast-growing Omicron variant from southeast Mexico bearing relevant escape mutations

R García-López, X Rivera-Gutiérrez, M Rosales-Rivera… - Infection, 2023 - Springer
Purpose The swift expansion of the BW. 1 SARS-CoV-2 variant coincided with a rapid
increase of COVID-19 cases occurring in Southeast Mexico in October, 2022, which marked …

Exploration of low-frequency allelic variants of SARS-CoV-2 genomes reveals coinfections in Mexico occurred during periods of VOCs turnover

R García-López, B Taboada, S Zárate… - Microbial …, 2024 - microbiologyresearch.org
A total of 14 973 alleles in 29 661 sequenced samples collected between March 2021 and
January 2023 by the Mexican Consortium for Genomic Surveillance (CoViGen-Mex) and …

Sequence signatures within the genome of SARS-CoV-2 can be used to predict host source

J Rudar, P Kruczkiewicz, O Vernygora… - Microbiology …, 2024 - Am Soc Microbiol
We conducted an in silico analysis to better understand the potential factors impacting host
adaptation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in white …